{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:55:36Z","timestamp":1778853336409,"version":"3.51.4"},"reference-count":57,"publisher":"American Association for Cancer Research (AACR)","issue":"10","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Purpose: To identify potential prognostic molecular factors in ampullary adenocarcinoma that could be of significant importance. To this end, we examined the possible prognostic significance of cyclooxygenase-2 (Cox-2) and Survivin expression and the apoptotic index in a cohort of uniformly treated patients with ampullary cancer treated with radical surgical excision.<\/jats:p>\n               <jats:p>Experimental Design: The entry criteria were that the patients have a pathologic diagnosis of ampullary cancer which had been resected. Expression analysis for Cox-2 and Survivin was done by immunohistochemical staining. Apoptotic cells were identified by the terminal deoxyribonucleotidyl transferase\u2013mediated dUTP nick-end labeling (TUNEL) method.<\/jats:p>\n               <jats:p>Results: Thirty-nine tumor specimens from resected ampullary adenocarcinoma patients were included. By univariate analysis, overall survival was affected by Cox-2 expression and TUNEL staining (respectively, P = 0.0003 and 0.03). Survivin expression did not influence the overall survival in our patient population (P = 0.123). Patients' clinicopathologic features (gender, age, and T and N factors) did not influence outcome. In multivariate Cox regression analysis, Cox-2 expression (relative risk, 4.330; P = 0.005) was the only variable that significantly affected overall survival.<\/jats:p>\n               <jats:p>Conclusions: The results of the present article provide, for the first time, evidence that Cox-2 expression, but not Survivin expression, may represent a significant prognostic factor after surgical resection in patients affected by cancer of the ampulla of Vater. Further studies are required to determine whether Cox-2 inhibitors may be useful for the therapy or prevention of ampullary carcinoma.<\/jats:p>","DOI":"10.1158\/1078-0432.ccr-04-2136","type":"journal-article","created":{"date-parts":[[2005,9,21]],"date-time":"2005-09-21T23:46:37Z","timestamp":1127346397000},"page":"3784-3789","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cyclooxygenase-2 Overexpression Is Associated with a Poor Outcome in Resected Ampullary Cancer Patients"],"prefix":"10.1158","volume":"11","author":[{"given":"Daniele","family":"Santini","sequence":"first","affiliation":[{"name":"1University Campus Bio-Medico;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Vincenzi","sequence":"additional","affiliation":[{"name":"1University Campus Bio-Medico;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Tonini","sequence":"additional","affiliation":[{"name":"1University Campus Bio-Medico;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Scarpa","sequence":"additional","affiliation":[{"name":"2Department of Experimental Medicine and Pathology, University \u201cLa Sapienza\u201d; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fortunata","family":"Vasaturo","sequence":"additional","affiliation":[{"name":"2Department of Experimental Medicine and Pathology, University \u201cLa Sapienza\u201d; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Malacrino","sequence":"additional","affiliation":[{"name":"2Department of Experimental Medicine and Pathology, University \u201cLa Sapienza\u201d; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Vecchio","sequence":"additional","affiliation":[{"name":"3Catholic University of the Sacred Heart, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Borzomati","sequence":"additional","affiliation":[{"name":"1University Campus Bio-Medico;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Valeri","sequence":"additional","affiliation":[{"name":"1University Campus Bio-Medico;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Coppola","sequence":"additional","affiliation":[{"name":"1University Campus Bio-Medico;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Magistrelli","sequence":"additional","affiliation":[{"name":"3Catholic University of the Sacred Heart, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"Nuzzo","sequence":"additional","affiliation":[{"name":"3Catholic University of the Sacred Heart, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelio","family":"Picciocchi","sequence":"additional","affiliation":[{"name":"3Catholic University of the Sacred Heart, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2005,5,16]]},"reference":[{"key":"2022061104164649400_B1","unstructured":"Brennan MF. Surgical management of peripancreatic cancer. In: Bland KI, Karakousis CP, Copeland EM, editors. Atlas of Surgical Oncology. Philadelphia: WB Saunders Company; 1995. p. 473\u201385."},{"key":"2022061104164649400_B2","doi-asserted-by":"crossref","unstructured":"Benhamiche AM, Jouve JL, Manfredi S, Prost P, Isambert N, Faivre J. Cancer of the ampulla of Vater: results of a 20-year population-based study. Eur J Gastroenterol Hepatol\u20082000;12:75\u20139.","DOI":"10.1097\/00042737-200012010-00014"},{"key":"2022061104164649400_B3","doi-asserted-by":"crossref","unstructured":"Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg\u20081990;211:447\u201358.","DOI":"10.1097\/00000658-199004000-00011"},{"key":"2022061104164649400_B4","doi-asserted-by":"crossref","unstructured":"Howe JR, Klimstra DS, Moccia RD, Conlon KC, Brennan MF. Factors predictive of survival in ampullary carcinoma. Ann Surg\u20081998;228:87\u201394.","DOI":"10.1097\/00000658-199807000-00013"},{"key":"2022061104164649400_B5","doi-asserted-by":"crossref","unstructured":"Achille A, Baron A, Zamboni G, Di Pace C, Orlandini S, Scarpa A. Chromosome 5 allelic losses are early events in tumours of the papilla of Vater and occur at sites similar to those of gastric cancer. Br J Cancer\u20081998;78:1653\u201360.","DOI":"10.1038\/bjc.1998.738"},{"key":"2022061104164649400_B6","doi-asserted-by":"crossref","unstructured":"Scarpa A, Di Pace C, Talamini G, et al. Cancer of the ampulla of Vater: chromosome 17p allelic loss is associated with poor prognosis. Gut\u20082000;4446:842\u20138.","DOI":"10.1136\/gut.46.6.842"},{"key":"2022061104164649400_B7","doi-asserted-by":"crossref","unstructured":"Moore PS, Missiaglia E, Beghelli S, et al. Allelotype of ampulla of Vater cancer: highly frequent involvement of chromosome 11. J Cancer Res Clin Oncol\u20082004;11130:339\u201345.","DOI":"10.1007\/s00432-004-0549-8"},{"key":"2022061104164649400_B8","doi-asserted-by":"crossref","unstructured":"Ambrosini G, Adida C, Altieri DC. A novel antiapoptosis gene, Survivin, expressed in cancer and lymphoma. Nat Med\u20081997;3:917\u201321.","DOI":"10.1038\/nm0897-917"},{"key":"2022061104164649400_B9","doi-asserted-by":"crossref","unstructured":"Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by Survivin. Nature\u20081998;396:580\u20134.","DOI":"10.1038\/25141"},{"key":"2022061104164649400_B10","unstructured":"Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC. Developmentally regulated expression of the novel cancer anti-apoptosis gene Survivin in human and mouse differentiation. Am J Pathol\u20081998;52:43\u20139."},{"key":"2022061104164649400_B11","doi-asserted-by":"crossref","unstructured":"Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M, Altieri DC. Anti-apoptosis gene, Survivin, and prognosis of neuroblastoma. Lancet\u20081998;351:882\u20133.","DOI":"10.1016\/S0140-6736(05)70294-4"},{"key":"2022061104164649400_B12","unstructured":"Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apoptosis by Surviving predicts shorter survival rates in colorectal cancer. Cancer Res\u20081998;58:5071\u20134."},{"key":"2022061104164649400_B13","unstructured":"Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, Survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res\u20081998;58:1808\u201312."},{"key":"2022061104164649400_B14","doi-asserted-by":"crossref","unstructured":"Swana HS, Grossman D, Anthony JN, Weiss RM, Altieri DC. Tumor content of the antiapoptosis molecule Survivin and recurrence of bladder cancer. N Engl J Med\u20081999;341:452\u20133.","DOI":"10.1056\/NEJM199908053410614"},{"key":"2022061104164649400_B15","doi-asserted-by":"crossref","unstructured":"Hofmann HS, Simm A, Hammer A, Silber RE, Bartling B. Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer. J Cancer Res Clin Oncol\u20082002;128:554\u201360.","DOI":"10.1007\/s00432-002-0364-z"},{"key":"2022061104164649400_B16","doi-asserted-by":"crossref","unstructured":"Kennedy SM, O'Driscoll L, Purcell R, et al. Prognostic importance of Survivin in breast cancer. Br J Cancer\u20082003;88:1077\u201383.","DOI":"10.1038\/sj.bjc.6600776"},{"key":"2022061104164649400_B17","doi-asserted-by":"crossref","unstructured":"Schlette EJ, Medeiros LJ, Goy A, Lai R, Rassidakis GZ. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J Clin Oncol\u20082004;22:1682\u20138.","DOI":"10.1200\/JCO.2004.10.172"},{"key":"2022061104164649400_B18","doi-asserted-by":"crossref","unstructured":"Sarela AI, Verbeke CS, Ramsdale J, Davies CL, Markham AF, Guillou PJ. Expression of Survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma. Br J Cancer\u20082002;86:886\u201392.","DOI":"10.1038\/sj.bjc.6600133"},{"key":"2022061104164649400_B19","doi-asserted-by":"crossref","unstructured":"Trieb K, Lehner R, Stulnig T, Sulzbacher I, Shroyer KR. Survivin expression in human osteosarcoma is a marker for survival. Eur J Surg Oncol\u20082003;29:379\u201382.","DOI":"10.1053\/ejso.2002.1415"},{"key":"2022061104164649400_B20","doi-asserted-by":"crossref","unstructured":"Okada E, Murai Y, Matsui K, et al. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett\u20082001;163:109\u201316.","DOI":"10.1016\/S0304-3835(00)00677-7"},{"key":"2022061104164649400_B21","doi-asserted-by":"crossref","unstructured":"Altura RA, Olshefski RS, Jiang Y, Boue DR. Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade. Br J Cancer\u20082003;89:1743\u20139.","DOI":"10.1038\/sj.bjc.6601334"},{"key":"2022061104164649400_B22","doi-asserted-by":"crossref","unstructured":"Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A\u20081992;89:7384\u20138.","DOI":"10.1073\/pnas.89.16.7384"},{"key":"2022061104164649400_B23","doi-asserted-by":"crossref","unstructured":"Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem\u20081993;268:9049\u201354.","DOI":"10.1016\/S0021-9258(18)52976-8"},{"key":"2022061104164649400_B24","doi-asserted-by":"crossref","unstructured":"Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology\u20081994;107:1183\u20138.","DOI":"10.1016\/0016-5085(94)90246-1"},{"key":"2022061104164649400_B25","unstructured":"Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res\u20081997;57:1276\u201380."},{"key":"2022061104164649400_B26","doi-asserted-by":"crossref","unstructured":"Hwang D, Scollard D, Byrne J, Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst\u20081998;90:455\u201360.","DOI":"10.1093\/jnci\/90.6.455"},{"key":"2022061104164649400_B27","unstructured":"Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res\u20081998;58:2929\u201334."},{"key":"2022061104164649400_B28","unstructured":"Hida T, Yatabe Y, Achiwa H, et al. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res\u20081998;58:3761\u20134."},{"key":"2022061104164649400_B29","doi-asserted-by":"crossref","unstructured":"Denkert C, Winzer KJ, Muller BM, et al. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma. Cancer\u20082003;97:2978\u201387.","DOI":"10.1002\/cncr.11437"},{"key":"2022061104164649400_B30","doi-asserted-by":"crossref","unstructured":"Shi H, Xu JM, Hu NZ, Xie HJ. Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma. World J Gastroenterol\u20082003;9:1421\u20136.","DOI":"10.3748\/wjg.v9.i7.1421"},{"key":"2022061104164649400_B31","unstructured":"Khuri FR, Wu H, Lee JJ, et al. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res\u20082001;7:861\u20137."},{"key":"2022061104164649400_B32","doi-asserted-by":"crossref","unstructured":"Ferrandina G, Ranelletti FO, Legge F, et al. Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancer. Clin Cancer Res\u20082004;10:3117\u201323.","DOI":"10.1158\/1078-0432.CCR-1090-3"},{"key":"2022061104164649400_B33","doi-asserted-by":"crossref","unstructured":"Raspollini MR, Amunni G, Villanucci A, et al. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome. Gynecol Oncol\u20082004;92:806\u201312.","DOI":"10.1016\/j.ygyno.2003.12.023"},{"key":"2022061104164649400_B34","doi-asserted-by":"crossref","unstructured":"Baldi A, Santini D, Vasaturo F, et al. Prognostic significance of cyclooxygenase-2 (Cox-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma. Thorax\u20082004;59:428\u201333.","DOI":"10.1136\/thx.2003.008912"},{"key":"2022061104164649400_B35","unstructured":"Okami J, Yamamoto H, Fujiwara Y, et al. Overexpression of Cyclooxygenase-2 in Carcinoma of the Pancreas. Clin Cancer Res\u20081999;5:2018\u201324."},{"key":"2022061104164649400_B36","doi-asserted-by":"crossref","unstructured":"Yip-Schneider MT, Barnard DS, Billings SD, et al. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis\u20082000;2:139\u201346.","DOI":"10.1093\/carcin\/21.2.139"},{"key":"2022061104164649400_B37","unstructured":"Tucker ON, Dannenberg AJ, Yang EK, et al. Cyclooxygenase-2 Expression Is Up-Regulated in Human Pancreatic Cancer. Cancer Res\u20081999;59:987\u201390."},{"key":"2022061104164649400_B38","doi-asserted-by":"crossref","unstructured":"Kim HJ, Sohn TS, Lee KT, Lee JK, Paik SW, Rhee JC. Expression of cyclooxygenase-2 and its correlation with clinicopathologic factors of ampulla of vater cancer. J Korean Med Sci\u20082003;18:218\u201324.","DOI":"10.3346\/jkms.2003.18.2.218"},{"key":"2022061104164649400_B39","doi-asserted-by":"crossref","unstructured":"Sobin LH, Wittekind C. TNM classification of malignant tumours: UICC International Union against Cancer. 5th ed. New York, NY: Wiley-Liss; 2002.","DOI":"10.1002\/0471463752"},{"key":"2022061104164649400_B40","doi-asserted-by":"crossref","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc\u20081958;53:457\u201381.","DOI":"10.1080\/01621459.1958.10501452"},{"key":"2022061104164649400_B41","doi-asserted-by":"crossref","unstructured":"Peto R, Pike MC, Armitage P, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br J Cancer\u20081977;35:1\u201339.","DOI":"10.1038\/bjc.1977.1"},{"key":"2022061104164649400_B42","doi-asserted-by":"crossref","unstructured":"Cox DR. Regression models and life tables. J R Stat Soc\u20081972;34:187\u2013220.","DOI":"10.1111\/j.2517-6161.1972.tb00899.x"},{"key":"2022061104164649400_B43","doi-asserted-by":"crossref","unstructured":"Todoroki T, Koike N, Morishita Y, et al. Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann Surg Oncol\u20082003;10:1176\u201383.","DOI":"10.1245\/ASO.2003.07.512"},{"key":"2022061104164649400_B44","doi-asserted-by":"crossref","unstructured":"Bakaeen FG, Murr MM, Sarr MG, et al. What prognostic factors are important in duodenal adenocarcinoma? Arch Surg\u20082000;135:635\u201341.","DOI":"10.1001\/archsurg.135.6.635"},{"key":"2022061104164649400_B45","doi-asserted-by":"crossref","unstructured":"Howe JR, Klimstra DS, Moccia RD, Conlon KC, Brennan MF. Factors predictive of survival in ampullary carcinoma. Ann Surg\u20081998;228:87\u201394.","DOI":"10.1097\/00000658-199807000-00013"},{"key":"2022061104164649400_B46","unstructured":"Ajiki T, Kamigaki T, Hasegawa Y, et al. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater. Hepatogastroenterology\u20082001;48:1266\u201370."},{"key":"2022061104164649400_B47","doi-asserted-by":"crossref","unstructured":"Santini D, Tonini G, Vecchio FM, et al. Prognostic value of bax, bcl-2, p53 and TUNEL staining in patients with radically resected ampullary carcinoma. J Clin Pathol\u20082005;58:159\u201365.","DOI":"10.1136\/jcp.2004.018887"},{"key":"2022061104164649400_B48","doi-asserted-by":"crossref","unstructured":"Sarela AI, Verbeke CS, Ramsdale J, Davies CL, Markham AF, Guillou PJ. Expression of Survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma. Br J Cancer\u20082002;86:886\u201392.","DOI":"10.1038\/sj.bjc.6600133"},{"key":"2022061104164649400_B49","doi-asserted-by":"crossref","unstructured":"Shirahama T, Arima J, Akiba S, Sakakura C. Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder. Cancer\u20082001;92:188\u201393.","DOI":"10.1002\/1097-0142(20010701)92:1<188::AID-CNCR1308>3.0.CO;2-W"},{"key":"2022061104164649400_B50","doi-asserted-by":"crossref","unstructured":"Tatsuguchi A, Matsui K, Shinji Y, et al. Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue. Hum Pathol\u20082004;35:488\u201395.","DOI":"10.1016\/j.humpath.2003.10.025"},{"key":"2022061104164649400_B51","doi-asserted-by":"crossref","unstructured":"Denkert C, Winzer KJ, Muller BM, et al. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma. Cancer\u20082003;97:2978\u201387.","DOI":"10.1002\/cncr.11437"},{"key":"2022061104164649400_B52","unstructured":"Davies G, Salter J, Hills M, Martin LA, Sacks N, Dowsett M. Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer. Clin Cancer Res\u20082003;9:2651\u20136."},{"key":"2022061104164649400_B53","doi-asserted-by":"crossref","unstructured":"Moore BC, Simmons DL. Cox-2 inhibition, apoptosis, and chemoprevention by nonsteroidal anti-inflammatory drugs. Curr Med Chem\u20082000;7:1131\u201344.","DOI":"10.2174\/0929867003374273"},{"key":"2022061104164649400_B54","unstructured":"Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res\u20082002;62:6323\u20138."},{"key":"2022061104164649400_B55","doi-asserted-by":"crossref","unstructured":"Kojima M, Morisaki T, Uchiyama A, et al. Association of enhanced cyclooxygenase-2 expression with possible local immunosuppression in human colorectal carcinomas. Ann Surg Oncol\u20082001;8:458\u201365.","DOI":"10.1007\/s10434-001-0458-x"},{"key":"2022061104164649400_B56","unstructured":"Yao M, Kargman S, Lam EC, et al. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice. Cancer Res\u20082003;63:586\u201392."},{"key":"2022061104164649400_B57","doi-asserted-by":"crossref","unstructured":"Oshima M, Taketo MM. Cox selectivity and animal models for colon cancer. Curr Pharm Des\u20082002;8:1021\u201334.","DOI":"10.2174\/1381612023394953"}],"container-title":["Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/11\/10\/3784\/1919494\/3784-3789.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/11\/10\/3784\/1919494\/3784-3789.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T18:28:15Z","timestamp":1654972095000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article\/11\/10\/3784\/186112\/Cyclooxygenase-2-Overexpression-Is-Associated-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,15]]},"references-count":57,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2005,5,16]]},"published-print":{"date-parts":[[2005,5,15]]}},"URL":"https:\/\/doi.org\/10.1158\/1078-0432.ccr-04-2136","relation":{},"ISSN":["1078-0432","1557-3265"],"issn-type":[{"value":"1078-0432","type":"print"},{"value":"1557-3265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,15]]}}}